ABGH at AASLD 2021!
ABGH was well and fully represented at AASLD 2021! Please take a moment to review the amazing scholarship from our members below!
Rotonya M. Carr, MD, FACP
University of Washington
Seattle, WA
Obesogenic diet and alcohol induce metabolic dysfunction, steatosis, and glucose intolerance, POSTER
Deletion of ceramide synthase 6 (CerS6) improves hepatic steatosis and glucose homeostasis in ethanol-fed mice, POSTER
Fecal metabolomic signatures of bile and amino acids distinguish patients with NASH in the REGENERATE study compared to a healthy control population, POSTER OF DISTINCTION
Long-term clinical outcomes of patients with COVID-19 and chronic liver disease, ORAL
Diversity Committee Mentoring Session, MENTOR/SPEAKER
Jeremy Louissaint, MD
Columbia University Medical Center
NY, NY
Patient portal use is associated with lower 90-day readmissions in decompensated cirrhosis, POSTER
Clinical Practice SIG Poster Debrief, MODERATOR
Emmanuel McDonald DO, MBS
Larkin Community Hospital, South Miami
Miami, FL
Autoimmune Hepatitis in a Patient with Sarcoidosis, POSTER
Lauren D. Nephew, MD, MAE, MSC
Indiana University School of Medicine
Indianapolis, IN
Eliminating Health Disparities in Liver Disease, MEET THE EXPERT
Increasing Rates or Non-Cirrhotic HCC in Black Patients A Multi-Center Cohort Study, ORAL
Removal of Medicaid Restrictions were Associated with Increased Hepatitis-C Virus Treatment Rates, But Disparities Persist, POSTER
Omar T. Sims, PhD
University of Alabama at Birmingham
Birmingham, AL
Forecasting Future Hepatitis C Disease Burden Between Non-Hispanic Black, Non-Hispanic White, and Hispanic Older Adults in the United States, POSTER
Ashley Spann, MD, MSACI
Vanderbilt University Medical Center
Nashville, TN
Meet the Expert: Applying Machine Learning to Liver Disease
The impact of rural residence, geoeconomics, and health literacy on liver transplant outcomes, POSTER
Cirrhosis-related sarcopenia may never resolve after liver transplant, POSTER
Septal ™ is the strongest echocardiographic predictor of the new diagnostic criteria for cirrhotic cardiomyopathy for prediction of major adverse cardiovascular events after liver transplantation, POSTER
The utility of new versus old diagnostic criteria for cirrhotic cardiomyopathy in predicting major adverse cardiovascular events after liver transplantation, POSTER
Impact of Cirrhotic Cardiomyopathy on the Development of Acute Kidney Injury Among Patients With Cirrhosis, POSTER
The association of cirrhotic cardiomyopathy with liver disease severity, POSTER
Kidist K. Yimam, MD
California Pacific Medical Center
San Francisco, CA
AASLD Global Outreach and Engagement Committee, COMMITTEE MEMBER
Meeting the Challenges of Liver Health in Africa, SESSION SPEAKER